NantCell Announces New Celgene Investment

Immunotherapy Company Will Present Findings at the JP Morgan Healthcare Conference in San Francisco on January 7thSecond Round Crossover Funding Brings Celgene’s Investment to $105M in NantCell Valued at $4 BillionCurrently Enrolling Patients in Advanced...

NantHealth®, B. Braun Australia, GE Healthcare and iProcedures Join Forces to Bridge Connectivity Gap Between Patient Devices, Data and Medical Records at the Healthcare Information and Management Systems Society (HIMSS) Asia Pacific Conference

NantHealth demonstrates new DeviceConX™ features including enterprise support for larger health systems and high fidelity waveform capture BRISBANE, AUSTRALIA and CULVER CITY, CA - (November 7, 2018) — NantHealth (NASDAQ: NH), a leader in breakthrough...

Media Contact

Jen Hodson
Telephone: 562-397-3639